 Joaquin Espinosa
Concepts (438)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Down Syndrome | 29 | 2026 | 504 | 7.950 |
Why?
| | Tumor Suppressor Protein p53 | 17 | 2025 | 528 | 4.510 |
Why?
| | Transcription, Genetic | 13 | 2021 | 1486 | 2.050 |
Why?
| | Cyclin-Dependent Kinases | 7 | 2022 | 130 | 1.880 |
Why?
| | Transcriptome | 6 | 2025 | 1007 | 1.750 |
Why?
| | Transcriptional Activation | 7 | 2023 | 377 | 1.690 |
Why?
| | Neoplasms | 11 | 2025 | 2731 | 1.660 |
Why?
| | Janus Kinase Inhibitors | 2 | 2024 | 27 | 1.550 |
Why?
| | Chromosomes, Human, Pair 21 | 2 | 2024 | 42 | 1.460 |
Why?
| | Proteome | 5 | 2025 | 483 | 1.450 |
Why?
| | Piperidines | 2 | 2024 | 217 | 1.390 |
Why?
| | Pyrimidines | 3 | 2024 | 510 | 1.300 |
Why?
| | Interferons | 4 | 2023 | 194 | 1.170 |
Why?
| | Genomics | 2 | 2021 | 811 | 0.930 |
Why?
| | Human Development | 1 | 2025 | 22 | 0.930 |
Why?
| | Hypoxia | 2 | 2024 | 1163 | 0.920 |
Why?
| | Gene Regulatory Networks | 2 | 2021 | 309 | 0.900 |
Why?
| | Antineoplastic Agents | 5 | 2025 | 2162 | 0.900 |
Why?
| | Immunoglobulins | 1 | 2025 | 162 | 0.860 |
Why?
| | Erythropoiesis | 1 | 2024 | 56 | 0.860 |
Why?
| | Heme | 1 | 2024 | 75 | 0.840 |
Why?
| | Blood-Brain Barrier | 1 | 2025 | 146 | 0.820 |
Why?
| | Receptors, Interferon | 2 | 2023 | 52 | 0.810 |
Why?
| | Protein Phosphatase 2C | 1 | 2022 | 15 | 0.780 |
Why?
| | Gene Expression Regulation, Neoplastic | 8 | 2021 | 1439 | 0.770 |
Why?
| | Interferon-alpha | 3 | 2020 | 195 | 0.750 |
Why?
| | Cell Death | 2 | 2025 | 386 | 0.730 |
Why?
| | Metabolome | 2 | 2025 | 366 | 0.730 |
Why?
| | Transcription Factors | 9 | 2023 | 1706 | 0.730 |
Why?
| | Molecular Targeted Therapy | 1 | 2025 | 420 | 0.720 |
Why?
| | Blood | 1 | 2022 | 110 | 0.710 |
Why?
| | Arthritis, Psoriatic | 1 | 2021 | 21 | 0.710 |
Why?
| | Genes, Tumor Suppressor | 1 | 2021 | 84 | 0.670 |
Why?
| | Humans | 72 | 2025 | 141284 | 0.660 |
Why?
| | Proto-Oncogene Proteins c-mdm2 | 6 | 2025 | 65 | 0.660 |
Why?
| | Apoptosis | 11 | 2025 | 2487 | 0.650 |
Why?
| | Oncogenes | 1 | 2021 | 119 | 0.650 |
Why?
| | Databases, Genetic | 1 | 2021 | 244 | 0.640 |
Why?
| | Kynurenine | 2 | 2023 | 115 | 0.630 |
Why?
| | Sex Characteristics | 1 | 2025 | 783 | 0.630 |
Why?
| | Trisomy | 2 | 2019 | 78 | 0.610 |
Why?
| | Signal Transduction | 9 | 2024 | 5116 | 0.600 |
Why?
| | Heart Defects, Congenital | 2 | 2025 | 880 | 0.580 |
Why?
| | Tumor Suppressor Proteins | 2 | 2018 | 325 | 0.580 |
Why?
| | Enhancer Elements, Genetic | 1 | 2020 | 189 | 0.570 |
Why?
| | Cyclin-Dependent Kinase 8 | 6 | 2022 | 51 | 0.570 |
Why?
| | Autoimmunity | 2 | 2023 | 908 | 0.540 |
Why?
| | T-Lymphocyte Subsets | 1 | 2019 | 413 | 0.520 |
Why?
| | Case-Control Studies | 7 | 2025 | 3577 | 0.520 |
Why?
| | Animals | 28 | 2026 | 37328 | 0.500 |
Why?
| | CD57 Antigens | 1 | 2016 | 18 | 0.480 |
Why?
| | Abatacept | 1 | 2016 | 56 | 0.480 |
Why?
| | Cell Proliferation | 7 | 2025 | 2502 | 0.470 |
Why?
| | Interferon-gamma | 3 | 2026 | 784 | 0.430 |
Why?
| | Adult | 17 | 2025 | 39319 | 0.420 |
Why?
| | Cell Line, Tumor | 9 | 2023 | 3502 | 0.420 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 3 | 2024 | 287 | 0.400 |
Why?
| | Proteomics | 4 | 2025 | 1137 | 0.400 |
Why?
| | Mice | 16 | 2026 | 17969 | 0.400 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2018 | 641 | 0.400 |
Why?
| | Cyclins | 3 | 2022 | 91 | 0.380 |
Why?
| | Gene Expression Profiling | 5 | 2024 | 1761 | 0.380 |
Why?
| | Graft Rejection | 1 | 2016 | 545 | 0.370 |
Why?
| | Female | 28 | 2026 | 75814 | 0.360 |
Why?
| | Young Adult | 9 | 2025 | 13727 | 0.360 |
Why?
| | Datasets as Topic | 2 | 2022 | 124 | 0.350 |
Why?
| | Alzheimer Disease | 3 | 2025 | 600 | 0.340 |
Why?
| | Immunosuppressive Agents | 1 | 2016 | 855 | 0.340 |
Why?
| | CD4-Positive T-Lymphocytes | 2 | 2023 | 1111 | 0.340 |
Why?
| | Adolescent | 10 | 2025 | 22116 | 0.330 |
Why?
| | Cell Differentiation | 3 | 2024 | 1983 | 0.330 |
Why?
| | Triple Negative Breast Neoplasms | 3 | 2019 | 201 | 0.330 |
Why?
| | Cell Cycle Proteins | 4 | 2023 | 628 | 0.320 |
Why?
| | RNA Polymerase II | 4 | 2019 | 340 | 0.320 |
Why?
| | Cell Line | 5 | 2021 | 2863 | 0.310 |
Why?
| | Male | 19 | 2025 | 70140 | 0.300 |
Why?
| | Kidney Transplantation | 1 | 2016 | 680 | 0.300 |
Why?
| | Biomarkers | 5 | 2025 | 4180 | 0.300 |
Why?
| | Mediator Complex | 3 | 2022 | 61 | 0.300 |
Why?
| | Child, Preschool | 7 | 2025 | 11511 | 0.290 |
Why?
| | DNA-Binding Proteins | 4 | 2016 | 1483 | 0.270 |
Why?
| | Proto-Oncogene Proteins | 2 | 2023 | 621 | 0.260 |
Why?
| | Promoter Regions, Genetic | 4 | 2013 | 1244 | 0.260 |
Why?
| | Gene Expression Regulation | 3 | 2012 | 2600 | 0.260 |
Why?
| | Trypanosoma cruzi | 4 | 2000 | 40 | 0.250 |
Why?
| | Flow Cytometry | 3 | 2019 | 1182 | 0.250 |
Why?
| | Cytokines | 5 | 2024 | 2079 | 0.250 |
Why?
| | Candidiasis, Oral | 1 | 2026 | 19 | 0.240 |
Why?
| | Positive Transcriptional Elongation Factor B | 1 | 2006 | 29 | 0.240 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 4 | 2009 | 123 | 0.240 |
Why?
| | Cell Cycle | 2 | 2008 | 601 | 0.230 |
Why?
| | Middle Aged | 12 | 2025 | 34658 | 0.230 |
Why?
| | Child | 9 | 2025 | 22390 | 0.230 |
Why?
| | Phosphorylation | 4 | 2022 | 1753 | 0.230 |
Why?
| | Lung Neoplasms | 1 | 2018 | 2554 | 0.230 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2025 | 153 | 0.220 |
Why?
| | Metabolomics | 2 | 2021 | 702 | 0.220 |
Why?
| | Heart | 2 | 2025 | 616 | 0.220 |
Why?
| | Mechanotransduction, Cellular | 1 | 2025 | 116 | 0.220 |
Why?
| | Protein Binding | 5 | 2021 | 2233 | 0.210 |
Why?
| | Hemoglobin SC Disease | 1 | 2023 | 14 | 0.210 |
Why?
| | Homeodomain Proteins | 2 | 2019 | 514 | 0.200 |
Why?
| | Erythropoietin | 1 | 2024 | 98 | 0.200 |
Why?
| | Liposarcoma | 1 | 2023 | 30 | 0.200 |
Why?
| | Oxidative Phosphorylation | 1 | 2024 | 204 | 0.200 |
Why?
| | Glutamine | 1 | 2023 | 107 | 0.200 |
Why?
| | Cyclin C | 1 | 2022 | 2 | 0.200 |
Why?
| | Disease Models, Animal | 5 | 2026 | 4414 | 0.200 |
Why?
| | Eukaryotic Initiation Factor-2 | 1 | 2022 | 29 | 0.190 |
Why?
| | Diabetic Neuropathies | 1 | 2023 | 94 | 0.190 |
Why?
| | Growth Disorders | 1 | 2022 | 87 | 0.190 |
Why?
| | Centrosome | 2 | 2022 | 71 | 0.190 |
Why?
| | Hearing Loss, Sensorineural | 1 | 2022 | 68 | 0.190 |
Why?
| | Nuclear Proteins | 4 | 2023 | 718 | 0.180 |
Why?
| | Gene Silencing | 1 | 2023 | 198 | 0.180 |
Why?
| | Nervous System Diseases | 1 | 2025 | 278 | 0.180 |
Why?
| | Acetyltransferases | 1 | 2001 | 21 | 0.180 |
Why?
| | Cerebellar Neoplasms | 1 | 2023 | 179 | 0.180 |
Why?
| | Up-Regulation | 3 | 2021 | 851 | 0.170 |
Why?
| | Medulloblastoma | 1 | 2023 | 218 | 0.170 |
Why?
| | Access to Information | 1 | 2021 | 45 | 0.170 |
Why?
| | Hematopoiesis | 2 | 2021 | 193 | 0.170 |
Why?
| | Cilia | 2 | 2022 | 170 | 0.170 |
Why?
| | Stress, Physiological | 1 | 2024 | 449 | 0.170 |
Why?
| | Janus Kinase 1 | 1 | 2020 | 26 | 0.170 |
Why?
| | Janus Kinase 2 | 1 | 2020 | 32 | 0.170 |
Why?
| | RNA, Messenger | 4 | 2021 | 2815 | 0.170 |
Why?
| | Azetidines | 1 | 2020 | 46 | 0.170 |
Why?
| | Doxorubicin | 3 | 2007 | 369 | 0.170 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2022 | 314 | 0.160 |
Why?
| | Data Mining | 1 | 2021 | 115 | 0.160 |
Why?
| | MicroRNAs | 2 | 2018 | 693 | 0.160 |
Why?
| | Models, Biological | 1 | 2008 | 1810 | 0.160 |
Why?
| | Autoantigens | 1 | 2023 | 424 | 0.160 |
Why?
| | Anemia, Sickle Cell | 1 | 2023 | 267 | 0.160 |
Why?
| | Eosinophilic Esophagitis | 1 | 2024 | 328 | 0.160 |
Why?
| | Quinolinic Acid | 1 | 2019 | 7 | 0.160 |
Why?
| | Connective Tissue Diseases | 1 | 2020 | 85 | 0.160 |
Why?
| | Heart Diseases | 1 | 2023 | 337 | 0.160 |
Why?
| | Biosynthetic Pathways | 1 | 2019 | 25 | 0.160 |
Why?
| | DNA, Protozoan | 1 | 1999 | 32 | 0.160 |
Why?
| | Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2019 | 57 | 0.150 |
Why?
| | Cognitive Dysfunction | 1 | 2025 | 416 | 0.150 |
Why?
| | Transcription Factor AP-1 | 1 | 1999 | 86 | 0.150 |
Why?
| | Neurons | 2 | 2025 | 1611 | 0.150 |
Why?
| | Protozoan Proteins | 1 | 1999 | 88 | 0.150 |
Why?
| | Protein Domains | 2 | 2017 | 305 | 0.150 |
Why?
| | Occult Blood | 1 | 2018 | 38 | 0.150 |
Why?
| | Coinfection | 1 | 2020 | 131 | 0.150 |
Why?
| | Calcinosis | 1 | 2020 | 238 | 0.140 |
Why?
| | Genome, Human | 1 | 2021 | 420 | 0.140 |
Why?
| | Cell Survival | 2 | 2021 | 1123 | 0.140 |
Why?
| | Nedd4 Ubiquitin Protein Ligases | 1 | 2018 | 15 | 0.140 |
Why?
| | SOXB1 Transcription Factors | 1 | 2019 | 66 | 0.140 |
Why?
| | Forkhead Box Protein O3 | 1 | 2018 | 17 | 0.140 |
Why?
| | Transforming Growth Factor beta2 | 1 | 2018 | 36 | 0.140 |
Why?
| | rhoA GTP-Binding Protein | 1 | 2018 | 75 | 0.140 |
Why?
| | Mice, Inbred C57BL | 5 | 2020 | 5866 | 0.140 |
Why?
| | Epithelial Cells | 1 | 2024 | 1105 | 0.140 |
Why?
| | Kidney Function Tests | 2 | 2016 | 159 | 0.140 |
Why?
| | Stem Cell Niche | 1 | 2018 | 58 | 0.140 |
Why?
| | Bacterial Infections | 1 | 2020 | 244 | 0.140 |
Why?
| | Receptor, Notch1 | 1 | 2018 | 65 | 0.140 |
Why?
| | Cell Lineage | 1 | 2019 | 352 | 0.140 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2021 | 428 | 0.140 |
Why?
| | Inflammation | 2 | 2020 | 2840 | 0.130 |
Why?
| | Inpatients | 1 | 2022 | 513 | 0.130 |
Why?
| | Hypersensitivity | 1 | 2020 | 257 | 0.130 |
Why?
| | Binding Sites | 3 | 2014 | 1311 | 0.130 |
Why?
| | Cellular Senescence | 1 | 2019 | 218 | 0.130 |
Why?
| | CD8-Positive T-Lymphocytes | 2 | 2023 | 911 | 0.130 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2018 | 188 | 0.130 |
Why?
| | Leukemia, Biphenotypic, Acute | 1 | 2017 | 3 | 0.130 |
Why?
| | Prospective Studies | 3 | 2025 | 7805 | 0.130 |
Why?
| | Hedgehog Proteins | 1 | 2018 | 200 | 0.130 |
Why?
| | Proteins | 1 | 2023 | 1007 | 0.130 |
Why?
| | Reminder Systems | 1 | 2018 | 174 | 0.130 |
Why?
| | Protein Kinase Inhibitors | 2 | 2020 | 918 | 0.130 |
Why?
| | Febrile Neutropenia | 1 | 2016 | 6 | 0.130 |
Why?
| | Osteosarcoma | 1 | 2017 | 73 | 0.130 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2019 | 393 | 0.130 |
Why?
| | Histidine Kinase | 1 | 2016 | 33 | 0.130 |
Why?
| | T-Lymphocytes | 2 | 2022 | 1996 | 0.120 |
Why?
| | Antigens | 1 | 2018 | 349 | 0.120 |
Why?
| | Sulfonamides | 1 | 2020 | 576 | 0.120 |
Why?
| | Exosomes | 1 | 2017 | 105 | 0.120 |
Why?
| | Proteolysis | 1 | 2017 | 173 | 0.120 |
Why?
| | Chromatin | 4 | 2016 | 536 | 0.120 |
Why?
| | Colonic Neoplasms | 1 | 2018 | 244 | 0.120 |
Why?
| | Neurofilament Proteins | 3 | 2025 | 62 | 0.120 |
Why?
| | HCT116 Cells | 3 | 2019 | 80 | 0.120 |
Why?
| | Adenosine Triphosphatases | 1 | 2016 | 159 | 0.120 |
Why?
| | Lymphocyte Activation | 1 | 2019 | 1136 | 0.120 |
Why?
| | Ribosomal Proteins | 1 | 2015 | 92 | 0.120 |
Why?
| | Autophagy | 1 | 2018 | 283 | 0.120 |
Why?
| | Neoplasm Recurrence, Local | 2 | 2019 | 1075 | 0.120 |
Why?
| | Drug Resistance | 1 | 2016 | 149 | 0.110 |
Why?
| | Allografts | 1 | 2016 | 148 | 0.110 |
Why?
| | Hematopoietic Stem Cells | 1 | 2018 | 408 | 0.110 |
Why?
| | Patient Participation | 1 | 2018 | 427 | 0.110 |
Why?
| | Aging | 1 | 2025 | 1919 | 0.110 |
Why?
| | Nerve Tissue Proteins | 1 | 2019 | 605 | 0.110 |
Why?
| | Bone Neoplasms | 1 | 2017 | 249 | 0.110 |
Why?
| | Phenotype | 1 | 2023 | 3172 | 0.110 |
Why?
| | Azepines | 1 | 2015 | 99 | 0.110 |
Why?
| | Neoplastic Stem Cells | 1 | 2019 | 411 | 0.110 |
Why?
| | Gene Expression | 1 | 2019 | 1490 | 0.110 |
Why?
| | Infant | 3 | 2025 | 9820 | 0.110 |
Why?
| | Repressor Proteins | 1 | 2017 | 426 | 0.110 |
Why?
| | Carrier Proteins | 1 | 2018 | 738 | 0.110 |
Why?
| | Fibroblasts | 1 | 2019 | 1018 | 0.100 |
Why?
| | Early Detection of Cancer | 1 | 2018 | 432 | 0.100 |
Why?
| | Acetylation | 2 | 2007 | 245 | 0.100 |
Why?
| | ets-Domain Protein Elk-1 | 1 | 2013 | 12 | 0.100 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2016 | 757 | 0.100 |
Why?
| | Prognosis | 3 | 2019 | 4080 | 0.100 |
Why?
| | Mitogens | 1 | 2013 | 56 | 0.100 |
Why?
| | Immunologic Memory | 1 | 2016 | 358 | 0.100 |
Why?
| | Down-Regulation | 1 | 2015 | 636 | 0.100 |
Why?
| | Graft Survival | 1 | 2016 | 502 | 0.100 |
Why?
| | Disease Progression | 1 | 2021 | 2808 | 0.100 |
Why?
| | Immunohistochemistry | 2 | 2016 | 1724 | 0.100 |
Why?
| | Follow-Up Studies | 3 | 2019 | 5222 | 0.100 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2013 | 173 | 0.100 |
Why?
| | Polymerase Chain Reaction | 1 | 2016 | 1050 | 0.100 |
Why?
| | Amphotericin B | 1 | 2012 | 36 | 0.090 |
Why?
| | Feedback, Physiological | 1 | 2012 | 81 | 0.090 |
Why?
| | Spain | 2 | 2025 | 46 | 0.090 |
Why?
| | Tumor Cells, Cultured | 3 | 2019 | 959 | 0.090 |
Why?
| | Glomerular Filtration Rate | 1 | 2016 | 755 | 0.090 |
Why?
| | RNA Stability | 1 | 2012 | 116 | 0.090 |
Why?
| | Hypertension, Pulmonary | 1 | 2023 | 1939 | 0.090 |
Why?
| | Antifungal Agents | 1 | 2012 | 144 | 0.090 |
Why?
| | Protein Structure, Tertiary | 2 | 2006 | 858 | 0.090 |
Why?
| | Colorectal Neoplasms | 1 | 2018 | 811 | 0.080 |
Why?
| | Mass Screening | 1 | 2018 | 1309 | 0.080 |
Why?
| | Risk Factors | 3 | 2025 | 10490 | 0.080 |
Why?
| | Sirtuins | 1 | 2010 | 39 | 0.080 |
Why?
| | Kidney Failure, Chronic | 1 | 2016 | 599 | 0.080 |
Why?
| | HeLa Cells | 3 | 2013 | 642 | 0.080 |
Why?
| | Imidazoles | 2 | 2023 | 251 | 0.080 |
Why?
| | Intracellular Signaling Peptides and Proteins | 2 | 2023 | 465 | 0.080 |
Why?
| | Histones | 2 | 2007 | 641 | 0.070 |
Why?
| | S Phase | 1 | 2009 | 77 | 0.070 |
Why?
| | Enzyme Activation | 2 | 2008 | 784 | 0.070 |
Why?
| | Protamine Kinase | 1 | 2008 | 8 | 0.070 |
Why?
| | Receptors, Thyroid Hormone | 1 | 2008 | 18 | 0.070 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2023 | 2529 | 0.070 |
Why?
| | Kidney Diseases | 1 | 2012 | 409 | 0.070 |
Why?
| | Hydroxyurea | 2 | 2023 | 33 | 0.070 |
Why?
| | Severity of Illness Index | 1 | 2016 | 2904 | 0.070 |
Why?
| | Piperazines | 2 | 2023 | 375 | 0.070 |
Why?
| | Glial Fibrillary Acidic Protein | 2 | 2025 | 112 | 0.070 |
Why?
| | RNA | 1 | 2014 | 927 | 0.070 |
Why?
| | DNA Topoisomerases, Type II | 1 | 2007 | 45 | 0.070 |
Why?
| | Multiprotein Complexes | 1 | 2008 | 171 | 0.070 |
Why?
| | Radiation, Ionizing | 1 | 2007 | 80 | 0.070 |
Why?
| | Protein Kinases | 1 | 2009 | 307 | 0.070 |
Why?
| | Formaldehyde | 1 | 2007 | 65 | 0.070 |
Why?
| | Genome-Wide Association Study | 2 | 2025 | 1408 | 0.070 |
Why?
| | Glycolysis | 2 | 2024 | 325 | 0.060 |
Why?
| | RNA Precursors | 1 | 2007 | 156 | 0.060 |
Why?
| | Fluorouracil | 1 | 2007 | 207 | 0.060 |
Why?
| | DNA | 2 | 2006 | 1440 | 0.060 |
Why?
| | Endocardial Cushions | 1 | 2025 | 7 | 0.060 |
Why?
| | Kinetics | 2 | 2007 | 1620 | 0.060 |
Why?
| | Critical Illness | 1 | 2012 | 852 | 0.060 |
Why?
| | High Mobility Group Proteins | 1 | 2006 | 44 | 0.060 |
Why?
| | Transcription Factors, TFII | 1 | 2006 | 44 | 0.060 |
Why?
| | Candida albicans | 1 | 2026 | 57 | 0.060 |
Why?
| | Transcriptional Elongation Factors | 1 | 2006 | 38 | 0.060 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2006 | 136 | 0.060 |
Why?
| | Transcription Factor TFIIH | 1 | 2006 | 40 | 0.060 |
Why?
| | Protein Transport | 1 | 2007 | 446 | 0.060 |
Why?
| | Breast Neoplasms | 1 | 2018 | 2246 | 0.060 |
Why?
| | Ubiquitin Thiolesterase | 1 | 2025 | 60 | 0.060 |
Why?
| | Serine | 1 | 2006 | 148 | 0.060 |
Why?
| | Mice, Knockout | 3 | 2019 | 3042 | 0.060 |
Why?
| | Myocytes, Cardiac | 2 | 2025 | 530 | 0.050 |
Why?
| | Glucose | 1 | 2010 | 1027 | 0.050 |
Why?
| | Kidney | 1 | 2012 | 1482 | 0.050 |
Why?
| | Aged | 6 | 2025 | 24836 | 0.050 |
Why?
| | Protein Isoforms | 1 | 2006 | 397 | 0.050 |
Why?
| | Hemoglobin, Sickle | 1 | 2023 | 19 | 0.050 |
Why?
| | Disease Susceptibility | 1 | 2026 | 351 | 0.050 |
Why?
| | Headache | 1 | 2025 | 153 | 0.050 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 983 | 0.050 |
Why?
| | Xenograft Model Antitumor Assays | 2 | 2019 | 917 | 0.050 |
Why?
| | Glutamates | 1 | 2023 | 62 | 0.050 |
Why?
| | Intermediate Filaments | 1 | 2023 | 26 | 0.050 |
Why?
| | Activating Transcription Factor 4 | 1 | 2023 | 21 | 0.050 |
Why?
| | Proteasome Inhibitors | 1 | 2023 | 42 | 0.050 |
Why?
| | L-Selectin | 1 | 2023 | 24 | 0.050 |
Why?
| | Perforin | 1 | 2023 | 19 | 0.050 |
Why?
| | Proline | 1 | 2023 | 80 | 0.050 |
Why?
| | Tyrosine | 1 | 2023 | 229 | 0.050 |
Why?
| | Patient Acuity | 1 | 2023 | 48 | 0.050 |
Why?
| | Aged, 80 and over | 3 | 2025 | 7948 | 0.050 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2025 | 265 | 0.050 |
Why?
| | Protein Tyrosine Phosphatases | 1 | 2023 | 167 | 0.050 |
Why?
| | Bile Acids and Salts | 1 | 2023 | 156 | 0.050 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2023 | 159 | 0.050 |
Why?
| | Esophagus | 1 | 2024 | 261 | 0.050 |
Why?
| | Hemolysis | 1 | 2023 | 206 | 0.050 |
Why?
| | Cells, Cultured | 3 | 2018 | 4149 | 0.050 |
Why?
| | Centrioles | 1 | 2022 | 45 | 0.040 |
Why?
| | DNA Footprinting | 1 | 2001 | 33 | 0.040 |
Why?
| | Neuroimaging | 1 | 2024 | 278 | 0.040 |
Why?
| | Cytoskeletal Proteins | 1 | 2022 | 154 | 0.040 |
Why?
| | Extracellular Matrix | 1 | 2025 | 554 | 0.040 |
Why?
| | p300-CBP Transcription Factors | 1 | 2001 | 27 | 0.040 |
Why?
| | Nitric Oxide | 2 | 1997 | 894 | 0.040 |
Why?
| | Nerve Regeneration | 1 | 2001 | 58 | 0.040 |
Why?
| | Genes, Protozoan | 1 | 2000 | 13 | 0.040 |
Why?
| | Immunoblotting | 1 | 2001 | 308 | 0.040 |
Why?
| | Histone Acetyltransferases | 1 | 2001 | 63 | 0.040 |
Why?
| | RNA Helicases | 1 | 2000 | 31 | 0.040 |
Why?
| | Clonal Evolution | 1 | 2021 | 46 | 0.040 |
Why?
| | Neuropsychological Tests | 1 | 2025 | 1090 | 0.040 |
Why?
| | Oligonucleotide Probes | 1 | 1999 | 50 | 0.040 |
Why?
| | Interferon Type I | 1 | 2020 | 140 | 0.040 |
Why?
| | Electrophoresis | 1 | 1999 | 31 | 0.040 |
Why?
| | Toll-Like Receptors | 1 | 2020 | 187 | 0.040 |
Why?
| | Heterozygote | 1 | 2020 | 306 | 0.040 |
Why?
| | Germ-Line Mutation | 1 | 2020 | 168 | 0.040 |
Why?
| | Vesiculovirus | 1 | 2019 | 17 | 0.040 |
Why?
| | Genetic Testing | 1 | 2022 | 462 | 0.040 |
Why?
| | Antigens, Neoplasm | 1 | 2022 | 320 | 0.040 |
Why?
| | Purines | 1 | 2020 | 182 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-jun | 1 | 1999 | 56 | 0.040 |
Why?
| | Microtubules | 1 | 2022 | 282 | 0.040 |
Why?
| | STAT1 Transcription Factor | 1 | 2019 | 71 | 0.040 |
Why?
| | Drosophila melanogaster | 1 | 2001 | 234 | 0.040 |
Why?
| | Nanog Homeobox Protein | 1 | 2019 | 14 | 0.040 |
Why?
| | Immunotherapy | 1 | 2024 | 641 | 0.040 |
Why?
| | Postal Service | 1 | 2018 | 30 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-fos | 1 | 1999 | 191 | 0.040 |
Why?
| | Myelopoiesis | 1 | 2018 | 8 | 0.040 |
Why?
| | Immunotherapy, Adoptive | 1 | 2022 | 358 | 0.040 |
Why?
| | Lymphopoiesis | 1 | 2018 | 26 | 0.040 |
Why?
| | Recombinant Fusion Proteins | 1 | 2001 | 672 | 0.040 |
Why?
| | Arginine | 2 | 1997 | 256 | 0.040 |
Why?
| | Mice, 129 Strain | 1 | 2018 | 86 | 0.040 |
Why?
| | DNA, Single-Stranded | 1 | 1999 | 119 | 0.040 |
Why?
| | Mice, SCID | 1 | 2019 | 367 | 0.030 |
Why?
| | MCF-7 Cells | 1 | 2018 | 127 | 0.030 |
Why?
| | Receptors, Growth Factor | 1 | 2017 | 56 | 0.030 |
Why?
| | Amyloid beta-Peptides | 1 | 2020 | 233 | 0.030 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2025 | 2122 | 0.030 |
Why?
| | Antibodies | 1 | 1999 | 399 | 0.030 |
Why?
| | omega-N-Methylarginine | 1 | 1997 | 29 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2025 | 2929 | 0.030 |
Why?
| | Ubiquitin-Conjugating Enzymes | 1 | 2017 | 13 | 0.030 |
Why?
| | Mice, Inbred NOD | 1 | 2019 | 599 | 0.030 |
Why?
| | Rats | 1 | 2025 | 5556 | 0.030 |
Why?
| | Pyrazoles | 1 | 2020 | 482 | 0.030 |
Why?
| | Blotting, Western | 1 | 1999 | 1220 | 0.030 |
Why?
| | Interleukin-1 Receptor-Associated Kinases | 1 | 2017 | 37 | 0.030 |
Why?
| | Epilepsy | 1 | 2001 | 359 | 0.030 |
Why?
| | Genetic Predisposition to Disease | 1 | 2025 | 2366 | 0.030 |
Why?
| | Host-Pathogen Interactions | 1 | 2019 | 369 | 0.030 |
Why?
| | Myeloid-Lymphoid Leukemia Protein | 1 | 2017 | 69 | 0.030 |
Why?
| | Neoplasm Metastasis | 1 | 2019 | 674 | 0.030 |
Why?
| | Mitosis | 1 | 2017 | 198 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2019 | 1261 | 0.030 |
Why?
| | Receptors, Estrogen | 1 | 2018 | 412 | 0.030 |
Why?
| | Tumor Protein p73 | 1 | 2015 | 18 | 0.030 |
Why?
| | Cholesterol | 1 | 2017 | 404 | 0.030 |
Why?
| | Aurora Kinase A | 1 | 2015 | 56 | 0.030 |
Why?
| | Histone-Lysine N-Methyltransferase | 1 | 2017 | 134 | 0.030 |
Why?
| | Hospitalization | 1 | 2025 | 2264 | 0.030 |
Why?
| | Immunity, Innate | 1 | 2020 | 847 | 0.030 |
Why?
| | Complement System Proteins | 1 | 2017 | 308 | 0.030 |
Why?
| | Survival Rate | 1 | 2019 | 1979 | 0.030 |
Why?
| | Genes, Immediate-Early | 1 | 2013 | 25 | 0.030 |
Why?
| | Cell Movement | 1 | 2018 | 962 | 0.030 |
Why?
| | Genes, ras | 1 | 2013 | 94 | 0.030 |
Why?
| | Protein Conformation | 1 | 2016 | 939 | 0.030 |
Why?
| | NIH 3T3 Cells | 1 | 2013 | 148 | 0.020 |
Why?
| | B-Lymphocytes | 1 | 2018 | 857 | 0.020 |
Why?
| | Interleukin-1 | 1 | 2017 | 970 | 0.020 |
Why?
| | Oxidative Stress | 1 | 1999 | 1327 | 0.020 |
Why?
| | Liver | 1 | 2020 | 1821 | 0.020 |
Why?
| | Biomarkers, Tumor | 1 | 2019 | 1250 | 0.020 |
Why?
| | Mycoses | 1 | 2012 | 86 | 0.020 |
Why?
| | Chronic Disease | 1 | 2017 | 1807 | 0.020 |
Why?
| | Retrospective Studies | 2 | 2024 | 16447 | 0.020 |
Why?
| | HEK293 Cells | 1 | 2013 | 738 | 0.020 |
Why?
| | Creatinine | 1 | 2012 | 491 | 0.020 |
Why?
| | Glucose Transporter Type 1 | 1 | 2010 | 48 | 0.020 |
Why?
| | Cell Respiration | 1 | 2010 | 106 | 0.020 |
Why?
| | Daunorubicin | 1 | 2009 | 25 | 0.020 |
Why?
| | Checkpoint Kinase 2 | 1 | 2009 | 29 | 0.020 |
Why?
| | Nucleic Acid Synthesis Inhibitors | 1 | 2009 | 16 | 0.020 |
Why?
| | Checkpoint Kinase 1 | 1 | 2009 | 28 | 0.020 |
Why?
| | Ataxia Telangiectasia Mutated Proteins | 1 | 2009 | 71 | 0.020 |
Why?
| | Coenzymes | 1 | 2008 | 19 | 0.020 |
Why?
| | Brain | 1 | 2001 | 2857 | 0.020 |
Why?
| | Caffeine | 1 | 2009 | 72 | 0.020 |
Why?
| | Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 2007 | 12 | 0.020 |
Why?
| | Substrate Specificity | 1 | 2008 | 380 | 0.020 |
Why?
| | RNA Caps | 1 | 2007 | 33 | 0.020 |
Why?
| | Genes, myc | 1 | 2007 | 49 | 0.020 |
Why?
| | Poly A | 1 | 2007 | 51 | 0.020 |
Why?
| | Topoisomerase II Inhibitors | 1 | 2007 | 26 | 0.020 |
Why?
| | DNA Replication | 1 | 2009 | 237 | 0.020 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2007 | 269 | 0.020 |
Why?
| | Dizocilpine Maleate | 2 | 1997 | 24 | 0.020 |
Why?
| | Cyclic GMP | 2 | 1997 | 91 | 0.020 |
Why?
| | Nitric Oxide Synthase | 2 | 1997 | 241 | 0.010 |
Why?
| | Mass Spectrometry | 1 | 2008 | 734 | 0.010 |
Why?
| | Recombinant Proteins | 1 | 2008 | 1362 | 0.010 |
Why?
| | Mutation | 1 | 2013 | 4006 | 0.010 |
Why?
| | Models, Molecular | 1 | 2007 | 1602 | 0.010 |
Why?
| | Cohort Studies | 1 | 2012 | 5809 | 0.010 |
Why?
| | Genomic Library | 1 | 2000 | 17 | 0.010 |
Why?
| | Microscopy, Electron | 1 | 2001 | 414 | 0.010 |
Why?
| | RNA, Protozoan | 1 | 2000 | 60 | 0.010 |
Why?
| | tau Proteins | 1 | 2001 | 96 | 0.010 |
Why?
| | DNA, Complementary | 1 | 2000 | 274 | 0.010 |
Why?
| | Amino Acid Motifs | 1 | 2000 | 223 | 0.010 |
Why?
| | Microtubule-Associated Proteins | 1 | 2001 | 198 | 0.010 |
Why?
| | Chromosome Mapping | 1 | 2000 | 502 | 0.010 |
Why?
| | Cell Culture Techniques | 1 | 2001 | 368 | 0.010 |
Why?
| | Biopsy | 1 | 2001 | 1073 | 0.010 |
Why?
| | Bucladesine | 1 | 1997 | 22 | 0.010 |
Why?
| | Guanosine Monophosphate | 1 | 1997 | 8 | 0.010 |
Why?
| | Guanosine Diphosphate | 1 | 1997 | 20 | 0.010 |
Why?
| | Amino Acid Sequence | 1 | 2000 | 2146 | 0.010 |
Why?
| | Molecular Sequence Data | 1 | 2000 | 2911 | 0.010 |
Why?
| | Amino Acid Oxidoreductases | 1 | 1995 | 18 | 0.010 |
Why?
| | Guanylate Cyclase | 1 | 1995 | 38 | 0.010 |
Why?
| | Citrulline | 1 | 1995 | 44 | 0.010 |
Why?
| | Glutamic Acid | 1 | 1997 | 256 | 0.010 |
Why?
| | Movement | 1 | 1997 | 289 | 0.010 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 1 | 1995 | 227 | 0.010 |
Why?
| | Amino Acids | 1 | 1997 | 491 | 0.010 |
Why?
| | Brain Neoplasms | 1 | 2001 | 1282 | 0.010 |
Why?
|
|
Espinosa's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|